Everloop 0.5 Tablet contains Everolimus 0.5 mg, a well-established mTOR inhibitor with strong immunosuppressive and antiproliferative properties. It is commonly prescribed for organ transplant patients to prevent graft rejection and for specific oncology indications requiring regulated cell growth control.
Everolimus works by inhibiting the mammalian target of rapamycin (mTOR) pathway, thereby suppressing T-cell activation and abnormal cellular proliferation. This mechanism supports long-term graft survival while helping reduce immune-mediated complications.
Clinically, Everloop 0.5 Tablet is used in renal and other solid organ transplant protocols and in selected cancer therapies, often as part of a carefully monitored treatment regimen to maintain therapeutic balance.
The tablet offers accurate dosing, consistent bioavailability, and dependable clinical performance, making it suitable for hospitals, transplant centers, and specialized oncology care settings where precise immunomodulation is essential.
Common side effects may include mouth ulcers, nausea, diarrhea, fatigue, rash, infections, and increased cholesterol or triglyceride levels. Rare but serious adverse effects include delayed wound healing, lung toxicity, bone marrow suppression, and severe infections.
Everloop 0.5 Tablet is indicated for the prevention of organ transplant rejection when used in combination with other immunosuppressive agents. It is also prescribed for the management of specific malignancies and benign tumors, including renal cell carcinoma, neuroendocrine tumors, and tuberous sclerosis complex–associated conditions, under specialist supervision.
Everloop 0.5 Tablet should be taken strictly as prescribed by a specialist. Regular monitoring of blood counts, renal function, lipid profile, and therapeutic drug levels is recommended. Inform your doctor about any existing infections, liver disorders, or concurrent medications. Avoid live vaccines and report symptoms such as persistent cough, fever, or shortness of breath immediately.
Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children. Do not use after the expiry date.